Expression and prognostic significance of CEACAM6, ITGB1, and CYR61 in peripheral blood of patients with gastric cancer

We examined CEACAM6, ITGB1, and cyr61 concentrations from patients with gastric cancers (GCs) to assess their clinical application for diagnosing and monitoring diseases.

[1]  D. Ichikawa,et al.  Circulating microRNAs in plasma of patients with gastric cancers , 2010, British Journal of Cancer.

[2]  Zhong-ying Shen,et al.  Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma , 2009, BMC Cancer.

[3]  L. Lesmana,et al.  Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[4]  Ming-Tsan Lin,et al.  Involvement of Hypoxia-inducing Factor-1α-dependent Plasminogen Activator Inhibitor-1 Up-regulation in Cyr61/CCN1-induced Gastric Cancer Cell Invasion* , 2008, Journal of Biological Chemistry.

[5]  E. Tokunaga,et al.  Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. , 2008, Hepato-gastroenterology.

[6]  Ming-Hsun Wu,et al.  Elevated Expression of Cyr61 Enhances Peritoneal Dissemination of Gastric Cancer Cells through Integrin α2β1* , 2007, Journal of Biological Chemistry.

[7]  B. Xiao,et al.  Detecting Carcinoma Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma by Immunomagnetic Beads and RT-PCR , 2007, Journal of clinical gastroenterology.

[8]  S. Hochwald,et al.  Significance of micrometastases in colorectal cancer , 2002, Annals of Surgical Oncology.

[9]  Ming-Hsun Wu,et al.  Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1. , 2007, The Journal of biological chemistry.

[10]  H. Kalthoff,et al.  Detection and clinical implications of minimal residual disease in gastro-intestinal cancer , 2005, Langenbeck's Archives of Surgery.

[11]  S. Ashley,et al.  CEACAM6 Is a Novel Biomarker in Pancreatic Adenocarcinoma and PanIN Lesions , 2005, Annals of surgery.

[12]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[13]  B. Xiao,et al.  Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers , 2004, Journal of Molecular Medicine.

[14]  H. Ito,et al.  CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness , 2004, British Journal of Cancer.

[15]  C. Raffaelli,et al.  Primary tumour staging of gastric and colorectal cancer , 2004, European Radiology.

[16]  R. Herrmann,et al.  Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Robert C. G. Martin,et al.  Extended Local Resection for Advanced Gastric Cancer: Increased Survival Versus Increased Morbidity , 2002, Annals of surgery.

[18]  F. Roviello,et al.  Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. , 2001, American journal of surgery.

[19]  S. Loening,et al.  Polymerase chain reaction in the detection of micrometastases and circulating tumor cells , 1996, Cancer.

[20]  H. Frierson,et al.  Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. , 1996, Clinical chemistry.

[21]  K. Hioki,et al.  Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients , 1994, Cancer.